This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ALOT's Q1 Adjusted EPS Declines Y/Y Due to Elevated Costs
by Zacks Equity Research
AstroNova's Q1 adjusted net income per share declines year over year despite strong segment growth, as higher costs and margin pressures weighed on profitability. It also reaffirms guidance for FY26.
The Zacks Analyst Blog Highlights NVIDIA, ICICI Bank, Fiserv, Bridger Aerospace and AstroNova
by Zacks Equity Research
Zacks spotlights NVDA, IBN, FI, BAER, and ALOT as analyst favorites, with AI, fintech, and aerospace themes driving investor attention.
AstroNova Incurs Q4 Loss as MTEX Integration Weighs, Stock Falls 21%
by Zacks Equity Research
ALOT's Q4 results hurt by MTEX integration and defense order and delivery delays, but 2026 outlook buoyed by new products, supply chain control and cost cuts.
The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova
by Zacks Equity Research
Walmart, Visa, AbbVie and AstroNova are included in this Analyst Blog.
Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie
by Sheraz Mian
A real-time update on the Q4 earnings season is part of today's Research Daily, in addition to fresh reports on Walmart (WMT), Visa (V), AbbVie (ABBV) and others, including a micro-cap stock AstroNova (ALOT).
AstroNova Stock Plunges 5.8% Since Q3 Earnings Release
by Zacks Equity Research
ALOT's Q3 earnings highlight 7.7% revenue growth, but margin pressures, MTEX integration challenges, and delayed launches weigh on profitability.
Zacks Initiates Coverage of AstroNova With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks has given AstroNova a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore the company's eco-friendly printing innovations and operational efficiencies alongside challenges from rising debt.
New Strong Sell Stocks for January 28th
by Zacks Equity Research
ALOT, GRWG, and LPL have been added to the Zacks Rank #5 (Strong Sell) List on January 28, 2022
Verisk (VRSK) Riding on Growth Strategies, Debt Woe Stays
by Zacks Equity Research
Verisk (VRSK) remains focused on organic growth, product development and acquisitions.
4 Breakout Stocks for Stunning Returns
by Nitish Marwah
ALOT, NMRK, UVE, and CFB are four of the 12 stocks that passed the screen for breakout stocks for today.
Lumen (LUMN) Q3 Earnings Top Estimates, Revenues Down Y/Y
by Zacks Equity Research
Lower revenues in each of the business units amid a challenging macroeconomic environment along with soft demand for IP and Data services hurt Lumen's (LUMN) third-quarter 2021 performance.
ALOT or TIXT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALOT vs. TIXT: Which Stock Is the Better Value Option?
ALOT or TIXT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALOT vs. TIXT: Which Stock Is the Better Value Option?
Arrow Electronics (ARW) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Despite supply chain issues, Arrow Electronics (ARW) achieves an all-time record in earnings per share, revenues and gross profit in the second quarter.
CDW Corporation (CDW) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Amid ongoing supply challenges, CDW Corporation (CDW) manages to deliver outstanding Q2 performance with record revenues of $5.15 billion, primarily driven by rebound in commercial customer spending.
ALOT or TRI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALOT vs. TRI: Which Stock Is the Better Value Option?
Mercury Systems (MRCY) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Mercury Systems' (MRCY) fiscal fourth-quarter results reflect benefits from newly acquired Physical Optics Corporation and Pentek businesses, continued deal wins and solid demand for its products.
Lumen (LUMN) Beats Q2 Earnings Estimates, Misses on Revenues
by Zacks Equity Research
Despite recording lower revenues in each of the business segments due to challenging macroeconomic environment, Lumen (LUMN) beats second-quarter 2021 earnings estimates.
ALOT vs. TRI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALOT vs. TRI: Which Stock Is the Better Value Option?
ALOT vs. TRI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALOT vs. TRI: Which Stock Is the Better Value Option?
AstroNova (ALOT) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
AstroNova (ALOT) has been struggling lately, but the selling pressure may be coming to an end soon.
360 DigiTech, Inc. Sponsored ADR (QFIN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
360 DigiTech, Inc. Sponsored ADR (QFIN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Down 11.8% in 4 Weeks, Here's Why You Should You Buy the Dip in AstroNova (ALOT)
by Zacks Equity Research
AstroNova (ALOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ALOT vs. TRI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALOT vs. TRI: Which Stock Is the Better Value Option?
AstroNova (ALOT) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
AstroNova (ALOT) has been struggling lately, but the selling pressure may be coming to an end soon